These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16158349)

  • 1. PharMillenium '99--the second world pharmaceutical congress and exhibition. Accelerating the pipeline: from drug discovery to market. 1-3 February 1999, Washington DC, USA.
    Fernandes M
    IDrugs; 1999 Apr; 2(4):304-8. PubMed ID: 16158349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Gene Therapy--second annual meeting. 9-13 June 1999, Washington DC, USA.
    Palmer K
    IDrugs; 1999 Aug; 2(8):741-4. PubMed ID: 16127643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered antibodies accelerating drug discovery and development.
    Zhu Z
    IDrugs; 2001 Dec; 4(12):1346-8. PubMed ID: 15931562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical new product development: the increasing role of in-licensing.
    Edwards NV
    Anesthesiol Clin; 2008 Dec; 26(4):627-36, v. PubMed ID: 19041620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Association of Pharmaceutical Scientists--annual meeting and exposition: drug discovery and development. 15-19 November 1998, San Francisco, CA, USA.
    Chamberlain J
    IDrugs; 1999 Jan; 2(1):26-8. PubMed ID: 16180164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic enzymes as therapeutic targets - Keystone Symposium. 3-8 February 2002, Keystone, CO, USA.
    Creemers J
    IDrugs; 2002 Mar; 5(3):216-9. PubMed ID: 15562329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research & market strategy: how choice of drug discovery approach can affect market position.
    Sams-Dodd F
    Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does brand differentiate pharmaceuticals?
    Bednarik J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Asthma, Allergy and Immunology--55th annual meeting. 26 February-3 March 1999, Orlando, FL, USA.
    Lieberman P
    IDrugs; 1999 May; 2(5):405-9. PubMed ID: 16155841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World pharmaceuticals--Financial Times tenth annual conference. 22-23 April 1999, London, UK.
    Muhsin M
    IDrugs; 1999 Jul; 2(7):650-2. PubMed ID: 16127632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10th annual drug discovery technology(®) europe and infotechpharma(®) conference.
    Kiyani S; Quigley E; Schlachter A; Treadway A
    Expert Opin Drug Discov; 2006 Jun; 1(1):91-4. PubMed ID: 23506035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global alcohol industry: an overview.
    Jernigan DH
    Addiction; 2009 Feb; 104 Suppl 1():6-12. PubMed ID: 19133910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective executive management in the pharmaceutical industry.
    Tran H; Kleiner BH
    J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfinished business: target-based drug discovery.
    Brown D
    Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA.
    Young SS
    IDrugs; 1999 Jul; 2(7):648-9. PubMed ID: 16127631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.